1. Market Research
  2. > Biotechnology

Biotech Industry Outlook: Latest Market Reports & Studies

  • Currently 3/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
12 votes

Global Biotechnology Industry

The global biotechnology industry is forecast to exceed $320 billion by 2015, reports Global Industry Analysts. Market growth is fuelled by economic recovery, increased R&D funding, government initiatives and biotechnology used in agriculture and medical sciences. Developing nations, particularly China and India, are becoming major markets in the fields of agricultural and industrial biotechnology.

The economic crisis negatively impacted the biotechnology market, and brought about revenue declines in the US and the EU as a result of limited capital inflows and the delay or cancellation of projects. The market has entered a phase of recovery, with many large biotechnology outfits generating revenue thanks to new cost-savings and efficiency measures.

Industry funding is on the rise on the back of more favorable economic conditions, though this funding is concentrated in a small number of larger outfits. Smaller companies are still struggling to raise R&D funds. The situation is likely to improve as venture capitalists exercise greater caution in seeking more secure investment options.

Biotech Key Market Segments

Biological Therapy - The biotechnology industry was further segmented in 2011, steered away from its traditional drug focus and into other fields, including cleantech and chemical manufacturing. BCC Research points to the focus on funding in low-possibility-of-success (POS) areas, such as antineoplastic and immunomodulating agents over other fields with greater success potential such as dermatology or acute diseases.

Genetic Testing represents an important market if we consider diagnosis as the key to better quality healthcare. This segment involves testing for chromosome, protein and gene abnormality or changes linked with inherited medical conditions. The global genetic testing industry is in a period of strong growth, fuelled by rising numbers of genetic disorders, better awareness and an aging population. The market was worth $1.5 billion in 2010, reports RNCOS.

The world genetic testing (and genomics) market is expected to reach $4 billion by 2015. Genetic testing for cancer is likely to experience one of the highest growth rates, receiving particular interest from the private sector and the scientific community at large. Direct-to-consumer genetic testing is a market segment that is likely to take off, with many new outfits on the market. Market shapers include 23andme and deCODE.

Biopharmaceuticals - Global enzyme demand is expected to grow, with the market expected to exceed $7.5 billion in 2010, according to Freedonia. The majority of markets are forecast to record yearly growth in of more than 5%, except for biofuel production and certain other smaller industrial enzyme segments. Regional growth rates will be highest in markets like the Africa/Mideast region, and Central and South America. Growth will be comparatively lower in established economies such as the US and the EU. Enzyme demand in North America will be negatively impacted by a slow switch over to biomass-based biofuel production. EU enzyme demand will be negatively impacted by the EU debt crisis.

Biotech Industry Regional Market Share

The US dominates the global biotechnology industry, followed by developed EU nations such as Germany, Spain, France and the UK, reports Global Industry Analysts. Developing nations like China and India are likely to record strong growth in agricultural and industrial biotechnology industries due to rising income levels and population. Both countries are playing an increasingly significant role in the biotech drugs market on the back of relatively low-cost investment and a high level of expertise.

Read more »

Share
24/7 Customer Support

Talk to Sam

+1 646 893 5945

1-10 of about 9300 reports

Global Biotechnology Overview

  • September 2017
    35 pages
  • Biotechnology  

    Biotech  

    Life Sciences  

  • United States  

    Europe  

    Germany  

View report >

Biotechnology Industry in Australia and the US

  • October 2017
    7 pages
  • Biotechnology  

  • Australia  

    United States  

View report >

Biotechnology Industry in Europe - Forecast

  • October 2017
    6 pages
  • Biotechnology  

    Industrial Biot...  

    Biochemical  

  • Europe  

    United Kingdom  

    Germany  

View report >

Biotechnology Industry in Australia and Japan

  • March 2015
    5 pages
  • Biotechnology  

  • Australia  

    Japan  

View report >

Biotechnology Industry in France

  • October 2016
    30 pages
  • Biotechnology  

    Biotech  

    Soybean  

  • France  

    Europe  

View report >

Biotechnology Statistics in Germany and Europe

  • May 2017
    68 pages
  • Germany  

    Europe  

    World  

View report >

Biotechnology Industry in Italy and Europe

  • January 2017
    17 pages
  • Biotechnology  

    Animal Biotechn...  

    Genetically Mod...  

  • Italy  

    Europe  

View report >

Industrial Biotechnology Industry in the UK

  • October 2017
    7 pages
  • Industrial Biot...  

  • United Kingdom  

    Europe  

View report >

Biotechnology Industry in Canada

  • January 2017
    28 pages
  • Biotechnology  

    Biotech  

  • Canada  

    North America  

View report >

The future of the Biotechnology Industry in Brazil

  • August 2015
    15 pages
  • Biotechnology  

    Biotech  

    Biochemical  

  • Brazil  

View report >

Search in Biotechnology Industry (About 9300 reports)
Related markets: Maize, Vaccine, Soybean, Hospital, Clinical Trial, Cell Therapy, Biosimilar, Genetic, Biotech, GMO, DNA, Stem Cell, Gene Therapy, Genome Sequencing, Tissue Engineering, Cytokine, Biomarker

About 2900 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 75 - $ 17678)

Cancer Biomarkers Market: Global Forecast until 2022

  • $ 7150
  • Industry report
  • October 2017
  • by MarketsandMarkets

“Global cancer biomarkers market projected to grow at CAGR of 12.2%”The global cancer biomarkers market is projected to reach USD 20.48 billion by 2022 from USD 11.53 billion in 2017, at a CAGR of ...

White Biotechnology Industry: Forecasts to 2024

August 2016 $ 5795

3D Cell Culture Market: Global Forecast until 2022

November 2017 $ 5650

Life Science Instrumentation Market: Global Forecast un ...

September 2017 $ 5650

Digital PCR and Real-time PCR Market: Forecast until 20 ...

June 2017 $ 5650

Veterinary Diagnostics Market: Global Forecast until 20 ...

April 2017 $ 5650

Next-Generation Sequencing Market: Global Forecasts unt ...

April 2017 $ 5650

Cell Sorting Market: Forecasts until 2021

January 2017 $ 5650

Bioinformatics Market: Global Analysis

October 2016 $ 5650

Food Enzymes Market: Global Forecasts until 2021

July 2016 $ 5650

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.